Calorie restriction and longevity: what the animal and human trials show
Reviewed 19 sourcesPublished by PepVault
Eating less made mice and monkeys live longer. In people, a 12% cut over 2 years lowered LDL and blood pressure and slowed an aging clock 2-3%, but cost bone.

- Last reviewed
- Sources
- 19
- Questions
- 8
- Compounds
- 2
The short answer
Calorie restriction is one of the most reliable ways to lengthen life in lab animals: 40% less food raised median lifespan in mice by 36%, and both big monkey studies found health gains, with longer life in one. Human lifespan is unmeasured. The first two-year trial, CALERIE, got healthy adults to eat 12% less: LDL, blood pressure and insulin resistance fell, an aging clock slowed 2-3%, and bone density dipped.
Evidence: Lifelong randomized studies in mice and rats, two long randomized studies in rhesus monkeys, and one 2-year randomized trial in healthy adults (CALERIE 2) that measured risk factors and biomarkers, not lifespan.

Does calorie restriction make animals live longer?
Yes, and it has for ninety years. Calorie restriction means eating fewer calories than you would by appetite, while still getting every vitamin, mineral and amino acid you need. In 1935, Clive McCay and colleagues reported that rats whose growth was held back by a restricted diet from a young age outlived rats that ate freely1.
The cleanest modern test is a 2024 study of 960 genetically diverse female mice, randomized to eat freely, to fast one or two days a week, or to eat 20% or 40% less, starting at 6 months of age. Life got longer in proportion to how much food was cut, and the 40% group lived about 9 months longer at the median, 36.3% more than the freely fed mice2. The same study found two costs: the 40% mice lost lean mass and showed immune changes that could make infections more likely, and genetics shaped lifespan more than the diet did2.
Genes matter enough to flip the result. When 41 inbred mouse strains were put on 40% restriction, it shortened life in more strains than it lengthened it3.
Species note: every lifespan result in this section is from mice and rats. No study has measured what calorie restriction does to human lifespan.

PepVault for iPhone
Keep your protocol in PepVault
PepVault's Food tab logs each meal's calories and protein against one daily target, worked out from your height, weight, age, sex and activity, so a cut like CALERIE's shows as a number you can see each day.
7 days free on the yearly plan for new subscribers.
Why did the two monkey studies disagree?
Two teams started rhesus monkey studies in the late 1980s, both cutting food by about 30%. In 2009 the University of Wisconsin team reported that, counting deaths from age-related causes, 80% of the restricted monkeys were still alive against 50% of the controls, with less diabetes, cancer, heart disease and brain shrinkage4. In 2012 the National Institute on Aging (NIA) team reported no gain in survival, although health measures improved5.
In 2017 both teams pooled their data in one paper and found the reasons7:
| What differed | Wisconsin | NIA |
|---|---|---|
| When restriction began | Adulthood only, about 7 to 14 years old | Young-onset and old-onset groups |
| How controls ate | Close to all they wanted | Measured rations, not free-fed |
| Sugar in the diet | Sucrose 45% of carbohydrate | Sucrose under 7% of carbohydrate |
| Fat in the diet | 10.6% by weight | 5.0% by weight |
| Survival result | Controls died at almost twice the rate (HR 1.87) | No significant difference in either onset group |
The NIA's controls were lean, healthy-diet monkeys on measured portions, so they were effectively on a mild restriction themselves, which shrinks the gap a study can find67. The NIA's old-onset monkeys lived so long that one restricted male reached 43, a record for the species7. In the NIA's young-onset group, age-related conditions still came at twice the rate in controls7. The joint verdict: the health benefits hold in monkeys, and when restriction starts and what the comparison group eats change the size of the survival effect7.
What happened when people tried it for two years?
CALERIE 2 was the first two-year randomized trial of calorie restriction in people who were not obese9. At three US centres, 218 healthy adults aged 21 to 50, with a body mass index (BMI, weight against height) of 22 to 28, were randomized 2:1 to cut calories by 25% for two years or to eat as usual89. A randomized controlled trial decides by chance who gets the change.
Nobody reached 25%. Measured with a lab method that tracks the energy people actually burn, the restricted group ate 11.9% less, from 2,467 to 2,170 calories a day, about 300 fewer9. 82% of them finished the two years8.
PepVault's Food tab logs each meal's calories and protein against one daily target, worked out from your height, weight, age, sex and activity, so a cut like CALERIE's shows as a number you can see each day. Track your food in PepVault
What did eating 12% less change in the body?
Each row is the restricted group's change at two years beside the usual-diet group, unless the row says otherwise.
| Measure | Restricted | Usual diet | Source |
|---|---|---|---|
| Weight | -7.5 kg (16.5 lb), 71% of it fat | +0.1 kg | 9 |
| Fat-free mass (muscle, organs, water) | -2.2 kg (4.9 lb) | -0.2 kg | 11 |
| LDL cholesterol | -0.23 mmol/L (about 9 mg/dL) from 2.51 (97 mg/dL) | +0.03 mmol/L | 9 |
| Systolic / diastolic blood pressure | -2.2 / -3.4 mm Hg | +2.2 / +1.6 mm Hg | 9 |
| Insulin resistance (HOMA-IR) | -0.36 from 1.11 | +0.03 | 9 |
| Pace of aging (DunedinPACE) | 2-3% slower at 12 and 24 months | Reference | 12 |
| Biological age clocks (PhenoAge, GrimAge) | No significant change | Reference | 12 |
| Thymus (makes new immune T cells) | Mass and volume up; more new T cells in blood | No change in volume | 13 |
| Energy burned (Pennington subgroup, 53 people) | 80-120 kcal a day below what the weight loss predicts | Reference | 14 |
| Bone density, total hip | -0.017 g/cm2 | +0.001 g/cm2 | 11 |
| Mood, general health, sex drive | Small improvements; no measure worse | Reference | 15 |
The heart and metabolic numbers are the solid result. LDL, blood pressure, insulin sensitivity, C-reactive protein (an inflammation marker) and a metabolic syndrome score all improved in people whose numbers were already normal, and held after allowing for the weight lost9.
The aging-clock result is the one that made news. DunedinPACE is a blood test that reads chemical tags on DNA (methylation) and estimates how fast the body is aging per calendar year. Restriction slowed it by 2-3%, more in people who cut over 10%12. It is a post hoc analysis, one run after the trial on stored blood, and two other clocks did not move12. The authors estimate from earlier observational data that a slowing this size could mean as much as 10-15% lower risk of death, a figure no trial has tested12.
The thymus, a gland behind the breastbone that makes new T cells, turns to fat with age. In scanned CALERIE participants, about 14% restriction for two years enlarged it and raised the count of newly made T cells in blood13. The restricted bodies also ran slower and made less oxidative damage14.
Commonly reported: people on long calorie cuts describe feeling colder and thinking about food more. In CALERIE, T3, the active thyroid hormone, fell more on restriction at 12 and 24 months, though core body temperature barely changed8.
PepVault charts your weigh-ins over time on the Body page, so you can see whether a change in eating is moving weight at the pace you meant. Track your weight in PepVault
What did it cost?
Bone and muscle. Bone mineral density fell at the spine, hip and femoral neck, the sites where osteoporotic fractures happen, and the bone team called that a possible limit of long restriction; whether exercise prevents it was left open11. About 2 kg of the weight lost was fat-free mass, though as a share of the body it went up, because more fat went1011. People who stayed most active held on to the most fat-free mass10.
The safety report counted no deaths and one serious adverse event on restriction; three people were withdrawn for safety reasons, and the authors advised watching for bone loss and anemia (low red blood cells)16. Within the restricted group, participants of normal weight had more nervous-system, musculoskeletal and reproductive complaints than those who started overweight16. The leaner you start, the less there is to gain.
So does calorie restriction help humans live longer?
Nobody knows yet: as of November 2026, no trial has measured human lifespan on restriction. Each species gives a different kind of answer:
| Species | Restriction | What was measured | Result |
|---|---|---|---|
| Mice (960, diverse genes) | 20% and 40%, from 6 months of age | Whole lifespan | Median life +36.3% at 40%2 |
| Mice (41 inbred strains) | 40% | Whole lifespan | Shortened life in more strains than it lengthened3 |
| Rhesus monkeys (Wisconsin + NIA) | About 30% | Survival over 25+ years | Longer life at Wisconsin; health gains at both7 |
| People (CALERIE 2) | 25% planned, 11.9% achieved | Risk factors and biomarkers, 2 years | Lower LDL, blood pressure, insulin resistance; aging pace 2-3% slower912 |
What the human trial does show is that a modest, sustained cut moves the risk factors that predict heart disease. Its volunteers were 38 on average and followed for two years, so lifespan was out of reach by design12.
Is a GLP-1 drug a form of calorie restriction?
In what it does to intake, partly yes. GLP-1 drugs such as semaglutide and tirzepatide quiet appetite, and in a 20-week trial in 72 adults with obesity, semaglutide 2.4 mg cut how much people ate at a single all-you-want lunch in the lab by 35% against placebo17. That is one meal, not a day's intake, so it does not compare directly with CALERIE's 11.9% cut over two years.
The two are not the same experiment. GLP-1 trials enrol people with obesity or diabetes, not lean volunteers, and the drug acts on the brain, gut and pancreas as well as on intake. In the outcome trial SELECT, 17,604 adults without diabetes, aged 45 or older with cardiovascular disease and overweight or obesity, had a 20% lower risk of heart attack, stroke or cardiovascular death on semaglutide over about 40 months of follow-up (HR 0.80)18. The same lesson on muscle carries over: a large cut takes lean mass with fat, which is why protein and strength training matter on a GLP-1. Whether one is right for you is your prescriber's call.
Who should not try calorie restriction?
- Anyone with an eating disorder now or in the past. Counting and cutting can pull the old pattern back.
- Pregnancy and breastfeeding. A growing baby needs the energy, and CALERIE did not study either.
- Children and teens. McCay's rats lived longer because their growth was held back1, which is not a goal for a child.
- Older adults and anyone already lean. In a trial of 160 older adults with obesity, those who dieted with aerobic exercise alone lost 5% of their lean mass and 3% of hip bone density in six months, while resistance training kept the losses to 2% and 0.5%19. CALERIE's normal-weight volunteers had more side complaints than its overweight ones16.
When to get help If cutting back starts to take over your thoughts, your periods stop, or you feel faint or keep losing weight you did not mean to lose, see a doctor.
Sources
- McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr. 1935;10:63-79. Reprinted in Nutrition. 1989;5(3):155-71. PubMed 2520283
- Di Francesco A et al. Dietary restriction impacts health and lifespan of genetically diverse mice. Nature. 2024;634:684-692. PubMed 39385029
- Liao CY et al. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell. 2010;9(1):92-5. PubMed 19878144
- Colman RJ et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325(5937):201-4. PubMed 19590001
- Mattison JA et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 2012;489(7415):318-21. PubMed 22932268
- Colman RJ et al. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun. 2014;5:3557. PubMed 24691430
- Mattison JA et al. Caloric restriction improves health and survival of rhesus monkeys. Nat Commun. 2017;8:14063. PubMed 28094793
- Ravussin E et al. A 2-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci. 2015;70(9):1097-104. PubMed 26187233
- Kraus WE et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(9):673-683. PubMed 31303390
- Das SK et al. Body-composition changes in the CALERIE-2 study: a 2-y randomized controlled trial of calorie restriction in nonobese humans. Am J Clin Nutr. 2017;105(4):913-927. PubMed 28228420
- Villareal DT et al. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J Bone Miner Res. 2016;31(1):40-51. PubMed 26332798
- Waziry R et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat Aging. 2023;3(3):248-257. PubMed 37118425
- Spadaro O et al. Caloric restriction in humans reveals immunometabolic regulators of health span. Science. 2022;375(6581):671-677. PubMed 35143297
- Redman LM et al. Metabolic slowing and reduced oxidative damage with sustained caloric restriction support the rate of living and oxidative damage theories of aging. Cell Metab. 2018;27(4):805-815. PubMed 29576535
- Martin CK et al. Effect of calorie restriction on mood, quality of life, sleep, and sexual function in healthy nonobese adults: the CALERIE 2 randomized clinical trial. JAMA Intern Med. 2016;176(6):743-52. PubMed 27136347
- Romashkan SV et al. Safety of two-year caloric restriction in non-obese healthy individuals. Oncotarget. 2016;7(15):19124-33. PubMed 26992237
- Friedrichsen M et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23(3):754-762. PubMed 33269530
- Lincoff AM et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232. PubMed 37952131
- Villareal DT et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017;376(20):1943-1955. PubMed 28514618
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.